The Cartagena Protocol on Biosafety to the Convention on Biological Diversity
The potential of modern biotechnology to contribute towards development has been recognized for some time. On the other hand, the potential adverse impacts on biodiversity, the environment as well as human and animal health is also of concern. Biosafety refers to the need to ensure the safe application of modern of modern biotechnology across all areas of its application from laboratory applications, handling, transport, field application, marketing etc. The Cartagena Protocol on Biosafety addresses in particular, Living Modified Organisms (LMOs) derived from modern biotechnology due to fears about potential impacts on biodiversity as well as human and animal health. The CPB was adopted on 29 January 2000 and opened for signature in May 2000 in Nairobi. It entered into force on 11 September 2003, ninety days after the 50th signature of ratification. Swaziland acceded on 13th June, 2006.
The Nagoya-Kuala Lumpur Supplementary Protocol on Liability and Redress to the Cartagena Protocol on Biosafety
The Nagoya-Kuala Lumpur Supplementary Protocol on Liability and Redress to the Cartagena Protocol on Biosafety was adopted on 15th October 2010 in Nagoya, Japan during the Fifth Conference of the Parties Serving as the Meeting of the Parties through decision BS-V/11. Read more >
The Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Use
The Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits arising from their Utilization (the Nagoya Protocol) was adopted in 2010 at the Tenth Meeting of Conference of Parties (COP 10) of the CBD in Nagoya, Japan, after 6 years of negotiation. Read more >